This meeting will cover CAPA methodology and documentation, diagnosing process improvement, developing options for process improvement and CAPA and planning and implementation in practice of improvements and CAPA
26 Jun 2020
& 4 Dec 2020
GBP 699 599 *
EUR 979 839 *
USD 1,090 934 *
* When you book before 1 May
In today’s highly regulated pharma, biotech, device and animal health industries, it is essential to use the most efficient processes and ensure compliance with an active corrective and preventive action (CAPA) system.
CAPA procedures are a frequent focus of regulatory inspectors and evidence will be required at any future inspections that CAPA actions have been implemented.
This course will provide you with an understanding of how to improve your processes and implement and document an effective CAPA quality system. The programme will include discussion of CAPA examples and case studies to enhance course learning.
Benefits of attending:This meeting runs back-to-back with How to Write SOPs and there is a further £100/€140 discount off this programme when booked together.
To find out more call Customer Services on +44 (0)20 7749 4730 or e-mail info@management-forum.co.uk
This course has been specifically designed for those working in the pharma, biotech, device or animal health industries who are involved in process improvement and CAPA requirements.
Why is CAPA important?
Best practice for CAPA
CAPA methodology and documentation
Diagnosing process improvement
Developing options for process improvement and CAPA
Planning and implementation in process improvements and CAPA
Laura Brown
Dr Laura Brown MBA, BSc,PhD, is a Pharmaceutical QA and Training Consultant, Course Director for the MSc in Clinical Research, School of Pharmacy at the University of Cardiff. She has more than 20 years’ experience of quality assurance in the pharmaceutical industry and has worked for several companies, including GSKs Hoechst Marion Roussel, Farmitalia and Phoenix International. She has a particular expertise in quality assurance including risked based approaches to quality systems, data Integrity and project management in the pharmaceutical industry. She regularly writes on pharmaceutical regulatory issues including “The Planning of International Drug Development”, in the Clinical Research Manual, Euromed and the “Impact of Brexit”, RQA Journal 2017.
| 26 Jun 2020 | ||||
| 26 Jun 2020 | Cavendish Hotel, London | GBP 699.00 EUR 979.00 USD 1,090.00 + VAT @ 20.00% |
GBP 599.00 EUR 839.00 USD 934.00 Until 1 May* |
Enrol now |
| 4 Dec 2020 | ||||
| 4 Dec 2020 | Venue not yet confirmed | GBP 699.00 EUR 979.00 USD 1,090.00 + VAT @ 20.00% |
Enrol now | |
* Note the early booking discount cannot be combined with any other offers or promotional code
“The course was well planned and executed. The balance of the course overhead slides and practical exercises were well balanced. This course is very good for anyone wanting to understand CAPA planning and Root Cause analysis. I would highly recommend this course to any Quality/ Production persons in the Pharma industry. Well done Management Forum! ”
Sameer Hashmi, Quality Associate, Animalcare
“Very good. ”
Heidrun Mylius, Senior Medical Writer & Process Improvement Manager, Medac GmbH
“Very clear, friendly and knowledgable. ”
Claire McGuinness, Medical Research Chemist, Mexichem
“Excellent speaker, good presentation and content. ”
Faiz Aziz, Technologist , Colorcon
“Excellent content, good speaker. Interacted with everyone. ”
Faiz Aziz, Technologist , Colorcon
“Pleasant, friendly, engaging and very knowledgable ”
Diana Kalmoni-Hassay, Reports, Submissions and Compliance Associate, GW Pharmaceuticals plc
“Informative and engaging. Thoroughly enjoyed it ”
Malgorzata Wilinska, Research Associate, University of Cambridge
“It was well packaged, concise and to the point.”
Bolutife Adeyemi, Senior PV Associate, GW Pharmaceuticals plc
“Very good, interesting and enjoyable ”
Chris Martin, Quality Engineer, Remote Diagnostic Technologies Ltd
“Very good overview”
Alexandra Beer, Senior Quality Manager, Animax Ltd
“Excellent”
Olga Vorobyeva, QMS Specialist , Arriello
“Useful course which I have definitely benefited from attending”
Ken Barratt, Production & Quality Manager, The National Artificial Eye Service
“Enjoyable course, with a very good presenter. ”
Sophie Thompson, Quality Engineer, Wesley Coe (Cambridge) Limited
“I found it useful and was happy to attend this course again”
Esther Janssen, Compliance Manager, Ferring Pharmaceuticals A/S
“Was about right, good fun approach and professional delivery”
Sandie Holmes, QA, Regulis Consulting Ltd
“Accurate and exhaustive content, very interesting presentation, alive presentation without borrowing time”
Karine Faller, Team leader QARA, Bernafon
“Very well put together and good use of group work. The course was very informative and used good examples for analysis. Good use of all participants present.”
Jas Sangha, Mundipharma Research Ltd
“Well thought through”
Liz King, Director of Research and Development, Oxford Pharmascience